Sarepta Therapeutics, Inc. (SRPT)
16.68
0.00 (0.00%)
USD |
NASDAQ |
May 27, 16:00
16.68
0.00 (0.00%)
After-Hours: 16:47
Sarepta Therapeutics Cash from Investing (Quarterly) : -134.39M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -93.74M |
| Keros Therapeutics, Inc. | -0.073M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| REGENXBIO, Inc. | 70.59M |
| Biogen, Inc. | -209.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -202.68M |
| Cash from Financing (Quarterly) | 0.241M |
| Free Cash Flow | 91.18M |
| Free Cash Flow Per Share (Quarterly) | -1.688 |
| Free Cash Flow to Equity (Quarterly) | -202.88M |
| Free Cash Flow to Firm (Quarterly) | -184.82M |
| Free Cash Flow Yield | 5.04% |